The aim of this study was to establish whether older patients with skin melanoma (in an analyzed group of 189 patients treated at the Institute for Oncology and Radiology of Serbia from 2004 to 2008), have worse survival compared to younger patients. In 100 men and 89 women with an average age of 58.9 years, the following parameters were observed and statistically analyzed in SPSS: gender, age, localization, tumor thickness, ulceration, lymphonodal status and invasion level. In the four age subgroups -quartiles, the best survival was shown in patients <50 years (85.7%), and the worst in patients >70 years (76.1%). Patients without ulcerations, with negative lymph nodes, thin melanomas and Clark levels I and II had significantly better survival outcomes. Although the results showed no statistical significance of age as a prognostic factor in the survival of patients with skin melanoma, further research on a larger number of patients is warranted.
INTRODUCTION
Melanoma is a relatively common malignancy. In Serbia, in around 500 patients with melanomas are detected yearly, and about 1000 patients are treated (Batut, 2010) . Serbia has one of the oldest populations in Europe, with an average age of 42 years (RZS, 2011) . Considering that skin melanoma is more common in the older population with a poorer prognosis (Payette et al., 2009) , with the younger population having better survival results, age most likely represents an important socio-epidemiological factor. The aim of this study was to establish whether older patients with skin melanomas have worse survival compared to younger ones.
MATERIALS AND METHODS
This retrospective study analyzed patients treated for skin melanoma at the Institute for Oncology and Radiology of Serbia (IORS) from 2004 to 2008. It included 189 patients, 100 men (52.9%) and 89 women (47.1%). The average age was 58.9 years, from 26 to 88 years. Data were collected from medical records of the IORS. All patients were divided by age into four age intervals − quartiles. The first quartile included patients younger than 50 years (N=49), the second included patients aged 51 to 58 years (N=48), the third quartile included patients aged 59 to 70 years (N=46) and the fourth those over 70 years (N=46). The following parameters were analyzed: demographic characteristics (age and gender); site of primary tumor; ulcerations; lymph node positivity; tumor thickness according to Breslow in millimeters (up to 2008 and 2009, ongoing classification) 
RESULTS

Age
The distribution of patients by age quartiles and their 5-year survival are given in Table 1 and Fig. 1 . Statistical analysis showed no statistically significant difference in 5-year survival of patients according to age, although better survival after 24 months was notable in the group of patients under 50 years of age in comparison to older groups (>70 years).
Gender
In the group of 100 male patients, 5-year survival was 80%, with lethal outcome during the followup in 20 patients. In 89 female patients, the 5-year survival was 87.6% (11 patients had lethal outcome). A log-rank test showed no statistically significant difference in survival of patients by gender. Fig. 1 . Distribution of cumulative probability of survival by age quartiles. Better survival after 24 months was notable in the group of patients under 50 years of age, in comparison to older group (>70 years).
Localization of primary tumor
As shown in Table 2 , the most frequent primary tumor localization in males was the dorsum (47%). In females, the most frequent localization was the lower limbs (40.4%). Statistical analysis showed highly significant difference in the distribution by gender (logrank test, p=0.003).
Ulceration
Ulceration of the primary tumor proved to be an important independent predictor of length of survival.
In the group of patients with no ulcerations (N=85), two patients had lethal outcome in the follow-up, meaning 5-year survival was 97.6%. On the other hand, in the group with ulcerations in the primary tumor (N=99), 26 patients died, with a 5-year survival of 73.7%. The log-rank test showed a highly significant difference in the survival of patients with regards to presence of ulceration in the primary tumor (p<0.001), which is represented in Fig. 2 . All patients were divided by age into four age quartiles. The first quartile included patients younger than 50 years, the second included patients aged 51 to 58 years, third quartile included patients aged from 59 to 70 years and the fourth those aged over 70 years.
Lymph node positivity
Results showed that lymph node status is also an important prognostic factor for survival. Among patients with negative lymph nodes (N=121), there were 12 deaths, which means that the 5-year survival was 90.1%. In the group of patients with positive lymph nodes (N=66), 5-year survival was 71.2% (19 patients died). The log-rank test showed a highly significant difference in the overall survival of patients in relation to positive findings in the lymph nodes (p<0.001), which is presented in Fig. 3 . 
Tumor thickness
Tumor thickness in millimeters (pathological tumornode-metastatis − pTNM) (Breslow, 1970 ) is shown in Table 3 . Patients with pTNM stage I and II had a better 5-year survival compared to patients with stages III and IV. The log-rank test showed a statistically significant difference in the 5-year survival of patients with pTNM stage I and III (p=0.037), as given in Fig. 4 . 
Thin vs. thick melanoma
With regard to stratum formation, in 2009 there was a change in the Breslow classification of melanoma (American Joint Committee on Cancer. 2009), and we divided the stratum accordingly. In the group of patients with thin melanoma (N=56), 5-year survival was 96.4% (2 patients died in the follow-up). In the group of patients with thick melanoma (N=126), 26 patients died. Their 5-year survival was 79.4%. Statistical analysis showed a highly significant difference in overall 5-year survival depending on the tumor thickness (log-rank test, p=0.007) (Fig. 5) . Clark level All 7 patients in Clark level I were alive in the followup period (5-year survival 100%). In Clark II (N=33), one death was recorded (5-year survival 97%). There were 80 patients in Clark III of whom 11 died during the follow-up (5-year survival 86.2%). Finally, in Clark IV (N=61), 16 patients died (5-year survival 73.8%). There was a highly significant difference in survival in the Clark IV vs. Clark III group (p=0.025) (Fig. 6 ). . Distribution of cumulative probability of survival by Clark. All patients in the Clark I were alive in the follow-up period (5-year survival 100%); 5-year survival in the Clark II group was 97%, in the Clark III group 86.2%, while in the Clark IV group it was 73.8%. Log rank test showed highly significant difference in survival in the Clark IV vs. Clark III group (p=0.025).
5-year survival of the whole stratum
In the tested group of 189 patients, overall 5-year survival was 61.3%, which is shown in the Kaplan-Meier survival curve (Fig. 7) . 
DISCUSSION
Our research did not distinguish age as а statistically significant prognostic factor in the 5-year survival of patients with skin melanoma. However, the distribution of cumulative probability of 5-year survival in age quartiles revealed clearly divergent patient groups: <50 years and >70 years of age, particularly after the 24 th month of follow-up. Identical results were shown in the studies by Khan et al. (1985) and Chang et al. (2003) . On the other hand, Austin et al. (1994) with 442 patients and Jatoi et al. (2012) with 233 patients showed patients' age as a statistically significant factor for survival prognosis. This difference in the obtained data is probably a consequence of different age-group stratification: we made four quartiles, Chang and Khan three, while Austin and Jatoi made two quartiles. Gender as a prognostic factor was not statistically distinguished in our research (females 87% vs. males 80%), similar to the finding of Balch et al. (2001) . There was a statistically significant difference in localization of primary tumor by gender (p=0.003), which is in accordance with available literature data (Ferlay et al., 2008; Tomàs-Mellebrera et al., 2010) . Ulceration is mentioned as important independent prognostic factor in many papers (Eigentler et al., 2004; Payette et al., 2009) . Our research showed significantly longer survival in patients without ulcerations (p<0.001): 5-year survival was 97.6% vs. 73.7% in patients with ulcerations. Lymph node positivity is also distinguished as a highly significant factor for poor prognosis (71.2% vs. 90.1% in negative lymph nodes, p<0.001). These results are similar to those obtained by different authors (Chang et al., 2003; Roulin et al., 2008; Fairbairn et al., 2012) . The figure curves in our study and those of Chang and Roulin are almost identical. It is also shown that pTNM and Clark stage are important independent prognostic factors (p=0.007 for pTNM; p=0.025 for Clark III vs. IV), which confirms results obtained by several authors (Austin et al., 1994; Payette et al., 2009; Rios et al., 2013) . As for the cumulative probability of survival of the whole patient stratum, the curves in our study, as well as those of Chang et al. (2003) , have the same statistical trend.
To conclude, our research did not reveal statistical significance in age as a prognostic factor in the survival of patients with skin melanoma, despite the results of studies with a larger population that unequivocally distinguish its significance. In our study, patients without ulcerations, with negative lymph nodes, thin melanomas and Clark levels I and II had significantly better survival.
